ET
OCUL icon

Entropy Technologies’s Ocular Therapeutix OCUL Stock Holding History

Entropy Technologies’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$131K Buy
+15,523
New +$148K 0.01% 838

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Entropy Technologies's OCUL Position: Q1 2026 in Review

Entropy Technologies opened a new position in Ocular Therapeutix (OCUL) in Q1 2026: 15,523 shares worth $131K. The stake represents 0.01% of the portfolio and ranks #838 among its holdings.

269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

  • Entropy Technologies held 15,523 shares of Ocular Therapeutix worth $131K as of Q1 2026.
  • Ocular Therapeutix was a new Entropy Technologies position in Q1 2026.
  • Ocular Therapeutix made up 0.01% of Entropy Technologies's portfolio in Q1 2026, its #838 holding.
  • 269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on Entropy Technologies's 13F filing for Q1 2026, filed 14 May 2026.